Dr B. Tholkappiyan

Managing Director

India’s pharmaceutical industry has emerged as one of the world’s most influential healthcare ecosys­tems, supplying affordable medicines to both domestic and international markets. According to the India Brand Equity Foundation (IBEF), the Indian pharmaceutical market is projected to reach $130 billion by 2030, driven by increasing healthcare awareness, ris­ing chronic diseases such as diabetes, and growing demand for cost-effective formulations.

India is also the world’s largest provider of generic medicines, contributing nearly 20 percent of global generic drug exports. In par­ticular, the anti-diabetes segment has witnessed strong momentum as life­style-related disorders continue to rise across developing economies.

Against this backdrop, Puducherry-based Thorab Pharma and Research Laboratory has positioned itself as a focused pharmaceutical manufacturer catering to the growing demand for high-quality oral formulations, including therapeutic categories linked to chronic disease management. Established in 2011, the company has steadily strengthened its manufacturing, research, and quality systems to support both domestic and export-oriented pharmaceutical requirements. With GMP-certified operations, an integrated quality assurance infrastructure, and a commitment to affordable healthcare solutions, Thorab represents the new generation of Indian pharmaceutical manufacturers contributing to the country’s expanding role in global healthcare supply chains.

Building a Quality-Driven Pharmaceutical Enterprise

Thorab Pharma and Research Laboratory was founded with the objective of manufacturing pharmaceutical formulations that meet stringent standards of quality, safety, and efficacy. Located in ThiruvandarKoil, Puducherry, the company operates a modern manufacturing facility designed in accordance with GMP and ISO 9001:2015 and ISO 22000:2015 standards. From its inception, Thorab has focused on developing reliable pharmaceutical products while simultaneously creating a scalable infrastructure capable of serving larger domestic and overseas markets.

The company manufactures a broad portfolio of oral dosage formulations including coated and uncoated tablets, capsules, and oral liquids. Its product categories span nutraceuticals, anti-inflammatory medicines, antihistamines, anti-ulcer drugs, haematinics, antifungal formulations, and other oral therapeutics. The facility also handles both β-lactam and non-β-lactam products, reflecting the company’s capability to manage diverse pharmaceutical manufacturing requirements within controlled environments.

What differentiates Thorab is its emphasis on integrating research, engineering, and manufacturing within a single operational framework. The company continues to invest in process development, technology transfer, and specialized formulations aimed at improving therapeutic outcomes and production efficiency.

Advanced Manufacturing with Regulatory Focus

Thorab’s manufacturing infrastructure reflects a strong alignment with current pharmaceutical regulatory expectations. The facility is equipped with dedicated production sections for tablets, capsules, and oral liquids, with separate floors allocated for β-lactam products to minimize contamination risks. Controlled HVAC systems, HEPA filtration, modular production concepts, and closed-loop water purification systems collectively support the company’s emphasis on contamination-free manufacturing.

The plant houses sophisticated production equipment, including fluid bed processors, compression machines, coating pans, capsule filling and polishing machines, blister packing systems, and oral liquid mixing tanks. The operational design follows unidirectional material flow principles to ensure process integrity and prevent cross-contamination. Multiple gowning procedures and controlled environmental systems further reinforce product safety and compliance.

Quality assurance remains central to Thorab’s manufacturing philosophy. The company operates an independent quality control laboratory equipped with advanced analytical instruments, such as HPLC systems, UV spectrophotometers, Karl Fischer titrators, dissolution testers, and microbiological testing facilities. The quality assurance team oversees validation, line inspection, stability monitoring, sanitation, documentation compliance, and regulatory adherence across all manufacturing stages.

“This strong focus on compliance and quality systems positions Thorab as a dependable manufacturing partner for contract manufacturing opportunities while also strengthening its standing in regulated pharmaceutical supply chains”, speaks Dr B. Tholkappiyan, Managing Director.

Research, Innovation, and Future Growth

Thorab continues to strengthen its research and development capabilities to support innovation-driven pharmaceutical manufacturing. The company’s R&D initiatives focus on faster product development cycles, robust process optimization, and commercially viable technology transfers. Its work includes novel oral dosage technologies, such as mouth-dissolving tablets, controlled-release formulations, effervescent tablets, bi-layered tablets, enteric-coated pellets, and specialized capsule systems.

This innovation-oriented strategy aligns with evolving market demands, where differentiated formulations and patient-centric drug delivery systems are becoming increasingly important. Thorab’s management believes that sustained innovation and quality enhancement are critical for long-term competitiveness in the pharmaceutical industry.

The company is led by Managing Director Lion. Dr. B. Tholkappiyan, an experienced pharmaceutical professional with expertise spanning quality control, quality assurance, manufacturing systems, validation protocols, and regulatory compliance. Under his leadership, Thorab has pursued an ethical, quality-driven growth model with ambitions to expand internationally through collaborations and export-oriented initiatives.

Looking ahead, Thorab has identified biotechnology and nanotechnology-based products as future growth drivers. This forward-looking vision reflects the company’s ambition to evolve from a regional pharmaceutical manufacturer into an integrated healthcare enterprise capable of addressing emerging therapeutic and technological opportunities.

By combining manufacturing excellence, regulatory compliance, research capability, and a strong commitment to affordable healthcare, Thorab Pharma and Research Laboratory continues to strengthen its role within India’s rapidly expanding pharmaceutical sector.